鶹ý

ART & Heart Safety; Eosinophil Counts Post MI; Antibiotics Fall Short After TAVR

— Recent developments of interest in cardiovascular medicine

MedpageToday
Cardio Break over a computer rendering of a heart.

Use of (ART) was not significantly associated with an increased long-term risk of cardiovascular diseases in women, according to a meta-analysis. (European Heart Journal)

A randomized trial in China showed that a improved medication adherence among patients with chronic heart failure. (JAMA Network Open)

Sixteen cardiology practices ponied up over $17 million to settle allegations that they violated the False Claims Act by , the U.S. Department of Justice announced.

A study suggested that changes in may predict post‐myocardial infarction (MI) mortality. (Journal of the American Heart Association)

After successfully resuscitated out-of-hospital cardiac arrest without ST-segment elevations, may be harmful, a post hoc Bayesian re-analysis of the TOMAHAWK and COACT trials showed. (JACC: Cardiovascular Interventions)

A of the Academic Research Consortium High Bleeding Risk criteria was validated for people undergoing percutaneous coronary intervention. (European Journal of Preventive Cardiology)

In a nationwide cohort study from Denmark, after transcatheter aortic valve replacement (TAVR) suggested that current prophylactic antibiotic regimens may not be providing adequate coverage. (Heart)

A small randomized trial was unable to show a benefit with for vessel recanalization or clinical outcomes following acute ischemic stroke. (Stroke)

The American College of Cardiology issued guidance for .

Abbott said the first implants of a have been completed as part of a feasibility study.

Stimulation of the sympathetic nervous system from the vertebral veins to help resolve rare at the time of catheter ablation showed promise in a small case series. (JAMA Cardiology)

Certain biomarker-defined were associated with mortality independently of Society for Cardiovascular Angiography & Interventions shock stages, according to a retrospective analysis of past trials. (eClinicalMedicine)

Mortality after was higher at hospitals without an investigational device exemption from the FDA. (JAMA Surgery)

A retrospective review showed an increase in uptake of in recent years, as an alternative to cardiac surgery with cardiopulmonary bypass. (Circulation)

  • author['full_name']

    Nicole Lou is a reporter for 鶹ý, where she covers cardiology news and other developments in medicine.